Search - tctmd.com

Displaying 121 - 140 of 180

Sort: Relevancy | Date

Presentation ECHO 2014

Right Heart Valvular Disease: When to Intervene

Presenter: Linda D. Gillam

April 09, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

March 24, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

L.A. McKeown

March 20, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

Presentation TCT 2013

Valvular Heart Disease: Best of EHJ

Presenter: Stephan Windecker

October 30, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

News Conference News TCT 2013

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

Presentation TCT 2013

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Anita Asgar

October 28, 2013

Presentation TCT 2013

Treatment Considerations in Patients with Valvular Heart Disease Requiring PCI: Stent Selection, Pharmacotherapy, and Timing

Presenter: James Hermiller Jr

October 28, 2013

News Conference News TCT 2013

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

October 28, 2013

Presentation TCT 2013

Valvular Heart Disease for the Interventionalist

Presenter: Susheel Kodali

October 27, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

Presentation ESC 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presenter: Alvaro Avezum

September 03, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Yael L. Maxwell

August 09, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

Presentation ECHO 2013

When (and how) to use Stress Testing in Valvular Heart Disease

Presenter: Jae K. Oh

April 03, 2013

Advertisement

Right Heart Valvular Disease: When to Intervene

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Las Nuevas Directrices sobre el Manejo de la Cardiopatía Valvular Integran Intervenciones basadas en Catéteres

Survival After Septal Ablation for HOCM Similar to General Population

Valvular Heart Disease: Best of EHJ

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Treatment Considerations in Patients with Valvular Heart Disease Requiring PCI: Stent Selection, Pharmacotherapy, and Timing

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

Valvular Heart Disease for the Interventionalist

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

When (and how) to use Stress Testing in Valvular Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content